6.16000 CAD
0.16
2.67%
Last update Dec 18, 3:59 PM EST
Market closed
Day range
6
6.53000
Previous close
6
Open
6.050000
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
6.16
0.16
2.67%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 4.4M 2.7M 3.1M 4.6M
Selling general and admin 1.7M 3.8M 2.9M 2.2M
Other operating expenses
Operating income -6.2M -6.5M -6.0M -6.8M
Non operating interest income
Income 77.1K 86.9K 107.8K 171.1K
Expense
Other income expense 1.9M -2.7M 2.0M -2.0M
Pretax income -4.2M -9.1M -3.9M -8.6M
Tax provision
Net income -4.2M -9.1M -3.9M -8.6M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 73.2M 72.0M 70.7M
Diluted average shares 73.2M 72.0M 70.7M
EBITDA -8.1M -3.7M -8.0M -4.8M
Net income from continuing op. -4.2M -9.1M -3.9M -8.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 14 hours 33 minutes

17:26
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EST, UTC-05:00).